Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Healius Limited ( (AU:HLS) ) has shared an update.
Healius Limited has announced the issuance of 45,955 unquoted equity securities in the form of NED Share Rights, effective November 10, 2025. This move is part of the company’s strategic financial operations, potentially impacting its market positioning and offering implications for its stakeholders.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$0.90 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited operates in the healthcare industry, providing a range of medical and healthcare services. The company is focused on delivering quality healthcare solutions and services to its clients, positioning itself as a key player in the healthcare market.
YTD Price Performance: -13.17%
Average Trading Volume: 4,579,639
Technical Sentiment Signal: Sell
Current Market Cap: A$631.7M
Learn more about HLS stock on TipRanks’ Stock Analysis page.